特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
956817

抗感染症薬市場 - 分析、市場規模、シェア、動向、予測:2021年~2027年

Anti-Infective Agents Market, By Type, By Distribution Channel, and By Geography - Analysis, Size, Share, Trends, & Forecast from 2021-2027

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 268 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
抗感染症薬市場 - 分析、市場規模、シェア、動向、予測:2021年~2027年
出版日: 2020年07月01日
発行: AnalystView Market Insights
ページ情報: 英文 268 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の抗感染症薬市場は、2019年までに1,138億米ドルに達し、2021年~2027年の予測期間中のCAGRで4.8%の成長が予測されています。院内感染、COVID-19、性感染症(STI)などの蔓延が、世界の抗感染症薬市場の成長を促進する主要な要因の1つです。

当レポートでは、世界の抗感染症薬市場について調査分析し、市場概要、市場力学、セグメント別の市場分析、競合情勢などについて、体系的な情報を提供しています。

目次

第1章 抗感染症薬市場概要

第2章 エグゼクティブサマリー

第3章 抗感染症薬市場の主要動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 抗感染症薬業界分析

  • ファイブフォース分析
  • マーケティング戦略分析
  • 成長見通しマッピング
  • 規制の枠組み分析

第5章 抗感染症薬市場:COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以降の影響分析

第6章 抗感染症薬市場情勢

  • 市場シェア分析
  • 主要イノベーター分析
  • 内訳データ:主要メーカー別

第7章 抗感染症薬市場:タイプ別

  • 概要
  • 抗菌薬
  • 抗真菌薬
  • 抗ウイルス薬
  • その他

第8章 抗感染症薬市場:流通チャネル別

  • 概要
  • 病院薬局
  • 専門薬局
  • Eコマース
  • 小売薬局
  • その他

第9章 抗感染症薬市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第10章 主要ベンダー分析

  • 競合ダッシュボード
  • 企業プロファイル

第11章 アナリストの見解

第12章 付録

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Anti-infective agents market: Types Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Types
  • TABLE Global anti-infective agents market, by Types 2016-2027 (USD Million)
  • TABLE Anti-infective agents market: Distribution Channel Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global anti-infective agents market, by Distribution Channel 2016-2027 (USD Million)
  • TABLE Anti-infective agents market: Regional snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global anti-infective agents market, by Region 2016-2027 (USD Million)
  • TABLE North America anti-infective agents market, by Country, 2016-2027 (USD Million)
  • TABLE North America anti-infective agents market, by Types, 2016-2027 (USD Million)
  • TABLE North America anti-infective agents market, by Distribution Channel, 2016-2027 (USD Million)
  • TABLE Europe anti-infective agents market, by Country, 2016-2027 (USD Million)
  • TABLE Europe anti-infective agents market, by Types, 2016-2027 (USD Million)
  • TABLE Europe anti-infective agents market, by Distribution Channel, 2016-2027 (USD Million)
  • TABLE Asia Pacific anti-infective agents market, by Country, 2016-2027 (USD Million)
  • TABLE Asia Pacific anti-infective agents market, by Types, 2016-2027 (USD Million)
  • TABLE Asia Pacific anti-infective agents market, by Distribution Channel, 2016-2027 (USD Million)
  • TABLE Latin America anti-infective agents market, by Country, 2016-2027 (USD Million)
  • TABLE Latin America anti-infective agents market, by Type, 2016-2027 (USD Million)
  • TABLE Latin America anti-infective agents market, by Distribution Channel, 2016-2027 (USD Million)
  • TABLE Middle East and Africa anti-infective agents market, by Country, 2016-2027 (USD Million)
  • TABLE Middle East and Africa anti-infective agents market, by Type, 2016-2027 (USD Million)
  • TABLE Middle East and Africa anti-infective agents market, by Distribution Channel, 2016-2027 (USD Million)

List of Figures

  • FIGURE Anti-infective agents market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2019
  • FIGURE Type segment market share analysis, 2020 & 2027
  • FIGURE Type segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Fluoroquinolones market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Macrolides market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Carbapenem market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Penicillin market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Cephalosporins market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Others market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Oral market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE IV market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Topical market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Others market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Azoles market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Polyenes market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Echinocandins market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Others market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Oral market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE IV market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Topical market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Others market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Protease Inhibitors market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Neuraminidase Inhibitors market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE DNA Polymerase Inhibitors market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Reverse Transcriptase Inhibitors market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Others market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Oral market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE IV market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Topical market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Others market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2020 & 2027
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Hospital Pharmacies market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Specialty Pharmacies market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE E-Commerce market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Retail Pharmacies market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Others market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Regional segment market share analysis, 2020 & 2027
  • FIGURE Regional segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE North America anti-infective agents market share and leading players, 2019
  • FIGURE Europe anti-infective agents market share and leading players, 2019
  • FIGURE Asia Pacific anti-infective agents market share and leading players, 2019
  • FIGURE Latin America anti-infective agents market share and leading players, 2019
  • FIGURE Middle East and Africa anti-infective agents market share and leading players, 2019
  • FIGURE North America market share analysis by country, 2019
  • FIGURE U.S. anti-infective agents market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Canada anti-infective agents market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Europe anti-infective agents market share analysis by country, 2019
  • FIGURE Germany anti-infective agents market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Spain anti-infective agents market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Italy anti-infective agents market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE UK anti-infective agents market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE France anti-infective agents market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of the Europe anti-infective agents market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Asia Pacific anti-infective agents market share analysis by country, 2019
  • FIGURE India anti-infective agents market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE China anti-infective agents market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Japan anti-infective agents market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE South Korea anti-infective agents market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Singapore anti-infective agents market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of APAC anti-infective agents market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America anti-infective agents market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America anti-infective agents market share analysis by country, 2019
  • FIGURE Brazil anti-infective agents market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Mexico anti-infective agents market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Argentina anti-infective agents market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of LATAM anti-infective agents market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa anti-infective agents market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa anti-infective agents market share analysis by country, 2019
  • FIGURE Saudi Arabia anti-infective agents market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE United Arab Emirates anti-infective agents market size, forecast and trend analysis, 2016 to 2027 (USD Million)
目次

Title:
Anti-Infective Agents Market, By Type (Anti-Bacterial, Antifungal, and Anti-Viral Agents), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, E-Commerce, and Retail Pharmacies), and By Geography (EU, NA, APAC, LATAM, and MEA) - Analysis, Size, Share, Trends, & Forecast from 2021-2027.

REPORT HIGHLIGHT

The global anti-infective agents market was valued at USD 113.8 billion by 2019, growing with 4.8% CAGR during the forecast period, 2021-2027.

The medicines that obstruct the spread of an infectious organism or kill the infectious microbe's outright are entitled as anti-infective. Anti-infective comprises antibiotics, antifungals, antimalarial, antivirals, etc. It plays an important role in revolutionizing the healthcare industry as it offers the treatment of minor infections and serious infectious diseases like tuberculosis (TB) and pneumonia. Besides these, it offers vital immune-suppressive treatment to patients with cancer and is used during complex surgeries or routine procedures that have a high risk of serious infections. As per the World Health Organization (WHO), September 2019, there were more than 50 antibiotics and combinations (with a new therapeutic entity) along with 10 biologics under the clinical pipeline that are targeting the WHO priority pathogens, TB and C.difficile. The major ones include Lascufloxacin, Cefiderocol, Zoliflodacin, Gepotidacin, among others.

Market Dynamics

Rising prevalence of infectious diseases such as hospital-acquired infections, COVID-19, and sexually transmitted infections (STIs) is one of the prime factors acknowledging the global anti-infective agent market growth. For instance, as per recent developments in regards to the count of confirmed COVID-19 cases (WHO data, 19th July 2020), around 14,043,176 people were affected by this deadly virus. Furthermore, 216 countries are affected by this infectious disease along with the count of total confirmed demise cases to be 597 583. Hence, the above-mentioned pointer serves to be the key determiner boosting the growth of the global market.

Moreover, the increasing funding from the government for the R&D activities related to the development of the COVID vaccine and the implementation of outstanding marketing strategies of the key players in the industry are expected to offer lucrative growth opportunities. For instance, in July 2020, the U.S. government granted US$1.6 billion to the vaccine development company Novavax, Inc. for cover testing, commercialization, and manufacturing of a potential coronavirus vaccine. The aim of this strategy was to deliver 100 million doses of coronavirus cure by January 2021. Thus, research analysts of AnalystView Market Insights opine that the anti-infective agent industry will continue to grow, owing to the favorable government initiatives coupled with new product developments.

On the contrary, the expensive research and development cost and intense competition among generic drug manufacturers are likely to obstruct the global business. Lack of awareness about the benefits and availability of drugs for infectious diseases in developing regions also serves to be the global anti-infective agent market challenge, decreasing the overall product demand.

Type Takeaway

Depending upon types, the global business is categorized into antibacterial agents, antifungals agents, and antivirals agents. The antibacterial market is sub-categorized into the type and route of administration. The antibacterial category comprises of Fluoroquinolones, Macrolides, Carbapenem, Penicillin, and Cephalosporins. The antifungals segment comprises Azoles, Polyenes, and Echinocandins. Furthermore, the antivirals are broadly fragmented into DNA polymerase inhibitors, protease inhibitors, neuraminidase inhibitors, and reverse transcriptase inhibitors.

The global market is dominated by the anti-bacterial agent, accounting for the rising number of prescriptions as per the current scenario coupled with the availability of a growing count of FDA approved drugs. For instance, in November 2019, the Food and Drug Administration approved 48 novel drugs, including that of antibacterial, antivirals, and anti-fungal. The list comprises Pretomanid tablets, Recarbrio, Avaclyr, and several others. The first one is extensively used for the treatment of non-responsive multidrug-resistant tuberculosis, whereas the last one is capable of curing inflammation of the cornea of the eye called acute herpetic keratitis.

Distribution Channel Takeaway

The distribution channel is categorized into hospital pharmacies, specialty pharmacies, e-commerce, and retail pharmacies. The hospital segment dominates the industry, owing to the increasing count of hospitals globally. As per the American Hospital Association, in 2020, the total number of all the U.S. hospitals accounts for 6,146. Similarly, the Center for Disease Dynamics, Economics & Policy (CDDEP) revealed that, in India, the total number of hospitals is 69,265, including both private and public hospitals.

Also, the intensive care of the patients in hospitals following by quick reimbursement aids in boosting the segment growth. Easy accessibility of drugs is also responsible for creating growth opportunities; thereby supporting the revenue growth over other distribution channels. Besides, the increasing per capita income coupled with the improving healthcare system in developing countries is also expected to shoot the market growth to the maximum verge of profits.

Regional Takeaway

North America leads the regional segment, owing to the presence of developed health care infrastructure coupled with the rising awareness about the benefits of the agents among end-users. Furthermore, the favorable reimbursement policies from the government of the developed nations such as North America and Europe are likely to influence industrial growth in a positive direction. For instance, the Center for Connected Health Policy (CCHP) updated its State Telehealth Laws & Reimbursement Policies, Fall 2019, covers the reimbursement of treatment opted for infectious diseases, along with trauma, burn, cardiology related telehealth coverage services.

Asia Pacific anti-infective agent market, in the same shoes, holds a significant share and is expected to grow at the fastest CAGR. Increasing investment by generic drug manufacturers and improving healthcare infrastructure are likely to shoot the growth with maximum profits.

COVID-19 Impact

The sudden outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) from China has diverted the focus of all the scientists and healthcare professionals towards the discovery of the cure. And, the global spread of COVID has now accelerated numerous ongoing researches for the discovery of a vaccine. One such study, named "Possible Therapeutic Agents for COVID-19: a comprehensive review", published in May 2020, covered the application of therapeutics that relieves the patients. As per the study, drugs like Ribavirin and Favipiravir can be used to cure COVID, as these drugs are antiviral. The former one has antiviral activity against hepatitis C virus, respiratory syncytial virus, and viral hemorrhagic fevers; whereas the latter one showed antiviral action against yellow fever, influenza A H1N1, and Ebola. However, still, no drug has been approved by the FDA that serves to be the appropriate cure. Henceforth, the above-mentioned indicators are the key determiners that have directly affected the growth of the global market.

Key Vendor Takeaway

The leading players of the market include Abbott, Astellas Pharma Inc., Bayer AG, Bristol-Myers Squibb Company, Gilead Sciences, Inc., GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer, Inc., and Sanofi. The proposed study offers a detailed profiling of players, and also includes useful insights that would help existing companies to increase revenue shares and new players willing to enter the market and thus help them in the decision-making process.

To participate and compete well in the industry, most of the companies are expanding their product portfolios and engaged in strategic collaborations by focusing on untapped opportunities. For instance, in July 2020, Nabriva Therapeutics plc announced the collaboration with the subsidiaries of Merck & Co. Inc., Kenilworth, N.J., USA. The terms of the collaboration included the marketing and distribution of SIVEXTRO (Tedizolid Phosphate Tablet) in the U.S. and certain of its territories.

The prominent players are also implementing excellent marketing strategies such as mergers, and acquisitions, to gain greater market share. For instance, in July 2020, Nabriva Therapeutics plc announced its partnership with Sunovion Pharmaceuticals Canada Inc. As per the collaboration, XENLETA will be marketed exclusively in Canada by Sunovion Pharmaceuticals Canada Inc.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year - 2016 to 2018

Base Year - 2019

Estimated Year - 2020

Projected Year - 2021 to 2027

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTI-INFECTIVE AGENTS MARKET KEY PLAYERS

Abbott

Astellas Pharma Inc.

Bayer AG

Bristol-Myers Squibb Company

Gilead Sciences, Inc.

GlaxoSmithKline plc.

Johnson & Johnson Services, Inc.

Merck & Co., Inc.

Novartis AG

Pfizer, Inc.

Sanofi

GLOBAL ANTI-INFECTIVE AGENTS MARKET, BY TYPE

Anti-bacterial Agents

Market, by Types

Fluoroquinolones

Macrolides

Carbapenem

Penicillin

Cephalosporins

Others

Market, by Route of Administration

Oral

IV

Topical

Others

Anti-fungal Agents

Market, by Types

Azoles

Polyenes

Echinocandins

Others

Market, by Route of Administration

Oral

IV

Topical

Others

Anti-viral Agents

Market, by Types

Protease Inhibitors

Neuraminidase Inhibitors

DNA Polymerase Inhibitors

Reverse Transcriptase Inhibitors

Others

Market, by Route of Administration

Oral

IV

Topical

Others

Others (Antiprotozoal, Anthelminthic etc.)

GLOBAL ANTI-INFECTIVE AGENTS MARKET, BY DISTRIBUTION CHANNEL

Hospital Pharmacies

Specialty Pharmacies

E-Commerce

Retail Pharmacies

Others

GLOBAL ANTI-INFECTIVE AGENTS MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

TABLE OF CONTENT

1. ANTI-INFECTIVE AGENTS MARKET OVERVIEW

  • 1.1. Study Scope

2. EXECUTIVE SUMMARY

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Type
    • 2.1.2. Market Snippet by Distribution Channel
    • 2.1.3. Market Snippet by Region
  • 2.2. Competitive Insights

3. ANTI-INFECTIVE AGENTS KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. ANTI-INFECTIVE AGENTS INDUSTRY STUDY

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. ANTI-INFECTIVE AGENTS MARKET: COVID-19 IMPACT ANALYSIS

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. ANTI-INFECTIVE AGENTS MARKET LANDSCAPE

  • 6.1. Market Share Analysis, 2019
  • 6.2. Key Innovators Analysis
  • 6.3. Breakdown Data, by Key Manufacturer
    • 6.3.1. Established Players' Analysis
    • 6.3.2. Emerging Players' Analysis

7. ANTI-INFECTIVE AGENTS MARKET - BY TYPE

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2020 & 2027 (%)
  • 7.2. Antibacterial Agents Market
    • 7.2.1. By Types
      • 7.2.1.1. Fluoroquinolones
      • 7.2.1.1.1. Overview
      • 7.2.1.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 7.2.1.2. Macrolides
      • 7.2.1.2.1. Overview
      • 7.2.1.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 7.2.1.3. Carbapenem
      • 7.2.1.3.1. Overview
      • 7.2.1.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 7.2.1.4. Penicillin
      • 7.2.1.4.1. Overview
      • 7.2.1.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 7.2.1.5. Cephalosporins
      • 7.2.1.5.1. Overview
      • 7.2.1.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 7.2.1.6. Others
      • 7.2.1.6.1. Overview
      • 7.2.1.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 7.2.2. By Route of Administration
      • 7.2.2.1. Oral
      • 7.2.2.1.1. Overview
      • 7.2.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 7.2.2.2. IV
      • 7.2.2.2.1. Overview
      • 7.2.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 7.2.2.3. Topical
      • 7.2.2.3.1. Overview
      • 7.2.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 7.2.2.4. Others
      • 7.2.2.4.1. Overview
      • 7.2.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • 7.3. Antifungal Agents Market
    • 7.3.1. By Types
      • 7.3.1.1. Azoles
      • 7.3.1.1.1. Overview
      • 7.3.1.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 7.3.1.2. Polyenes
      • 7.3.1.2.1. Overview
      • 7.3.1.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 7.3.1.3. Echinocandins
      • 7.3.1.3.1. Overview
      • 7.3.1.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 7.3.1.4. Others
      • 7.3.1.4.1. Overview
      • 7.3.1.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 7.3.2. By Route of Administration
      • 7.3.2.1. Oral
      • 7.3.2.1.1. Overview
      • 7.3.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 7.3.2.2. IV
      • 7.3.2.2.1. Overview
      • 7.3.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 7.3.2.3. Topical
      • 7.3.2.3.1. Overview
      • 7.3.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 7.3.2.4. Others
      • 7.3.2.4.1. Overview
      • 7.3.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • 7.4. Antiviral Agents Market
    • 7.4.1. By Types
      • 7.4.1.1. Protease Inhibitors
      • 7.4.1.1.1. Overview
      • 7.4.1.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 7.4.1.2. Neuraminidase Inhibitors
      • 7.4.1.2.1. Overview
      • 7.4.1.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 7.4.1.3. DNA Polymerase Inhibitors
      • 7.4.1.3.1. Overview
      • 7.4.1.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 7.4.1.4. Reverse Transcriptase Inhibitors
      • 7.4.1.4.1. Overview
      • 7.4.1.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 7.4.1.5. Others
      • 7.4.1.5.1. Overview
      • 7.4.1.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 7.4.2. Market, by Route of Administration
      • 7.4.2.1. Oral
      • 7.4.2.1.1. Overview
      • 7.4.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 7.4.2.2. IV
      • 7.4.2.2.1. Overview
      • 7.4.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 7.4.2.3. Topical
      • 7.4.2.3.1. Overview
      • 7.4.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 7.4.2.4. Others
      • 7.4.2.4.1. Overview
      • 7.4.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • 7.5. Others (Antiprotozoal, Anthelminthic etc.)
    • 7.5.1. Overview
    • 7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

8. ANTI-INFECTIVE AGENTS MARKET - BY DISTRIBUTION CHANNEL

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Distribution Channel, 2020 & 2027 (%)
  • 8.2. Hospital Pharmacies
    • 8.2.1. Overview
    • 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • 8.3. Specialty Pharmacies
    • 8.3.1. Overview
    • 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • 8.4. E-Commerce
    • 8.4.1. Overview
    • 8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • 8.5. Retail Pharmacies
    • 8.5.1. Overview
    • 8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • 8.6. Others
    • 8.6.1. Overview
    • 8.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

9. ANTI-INFECTIVE AGENTS MARKET- BY GEOGRAPHY

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 9.3.10. Rest of Europe
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 9.4.10. Rest of APAC
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 9.5.9. Rest of LATAM
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Types, 2016 - 2027 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

10. KEY VENDOR ANALYSIS

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Johnson & Johnson Services, Inc.
      • 10.2.1.1. Company Snapshot
      • 10.2.1.2. Financial Performance
      • 10.2.1.3. Product Benchmarking
      • 10.2.1.4. Strategic Initiatives
    • 10.2.2. Astellas Pharma Inc.
    • 10.2.3. Bayer AG
    • 10.2.4. Bristol-Myers Squibb Company
    • 10.2.5. Merck & Co., Inc.
    • 10.2.6. Novartis AG
    • 10.2.7. Abbott
    • 10.2.8. Gilead Sciences, Inc.
    • 10.2.9. GlaxoSmithKline plc.
    • 10.2.10. Pfizer, Inc.
    • 10.2.11. Sanofi

11. 360 DEGREE ANALYSTVIEW

12. APPENDIX

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.